ã±ã³ã¿ãããŒå·ãšã«ãªãã©ã«ãã¢å·ã®å»åž«ããã¡ãã£ã±ã€ãæ£è ã«COVIDã®ã¯ã¯ãã³ãæ¥çš®ããŠæ°çŸäžåã®ããŒãã¹å ±é ¬ãåãåã£ãŠããä»¶
å èšäºã¯ãã¡ããã/Click here to read the original article.
é£éŠæ¿åºãšä¿éºäŒç€Ÿã¯ãã±ã³ã¿ãããŒå·ãšã«ãªãã©ã«ãã¢å·ã®å»çæ©é¢ã«å¯Ÿããã¡ãã£ã±ã€ãæ£è ã«COVID-19ãæ¥çš®ãããããæ¥çš®ã«æåããæ£è ã®å²åã«å¿ããããŒãã¹ãæäŸããããšã§ã€ã³ã»ã³ãã£ããäžããŠããããšãææžã§æããã«ãªããŸããã
é£éŠæ¿åºãšä¿éºäŒç€Ÿã¯ãã±ã³ã¿ãããŒå·ãšã«ãªãã©ã«ãã¢å·ã®å»çæ©é¢ã«ãã¡ãã£ã±ã€ãæ£è ã«COVID-19ã®ã¯ã¯ãã³ãæ¥çš®ãããããæ¥çš®ã«æåããæ£è ã®å²åã«å¿ããããŒãã¹ãæäŸããããšã§ã€ã³ã»ã³ãã£ããäžããŠããŸããã
å ç§å»ã§çç©æŠç«åŠè ã®ã¡ãªã«ã»ãã¹å士ã¯ãèªèº«ã®Substackã«ãCOVID-19ã¯ã¯ãã³æäŸè ã€ã³ã»ã³ãã£ãã»ããã°ã©ã ã«é¢é£ããããã€ãã®ææžãæ²èŒãããïŒããã¯ïŒæ¬åœã«æ°æã¡æªãããšã§ãèªåã®è·æ¥ãæ¥ããããšã«ãªããŸãããšæžããã
ãã®ææžã¯ãã¯ã¯ãã³æ¥çš®çãäœãåŸåã«ããäœæåŸè ãæè²äººçš®ãã¿ãŒã²ããã«ããããŸããŸãªæŠç¥ãå±éãããé£éŠãå·ãå°æ¹ã¬ãã«ã§ã®å¹ åºãåãçµã¿ã®å šäœåãæãåºãã®ã«åœ¹ç«ã€ã
ãã®æŠç¥ã«ã¯ããæåçã«èª¿æŽããããã¯ã¯ãã³æšé²è³æã®äœæããCOVID-19ãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãåå·ã®æè²äººçš®ã³ãã¥ããã£ã«æšé²ãããä¿¡é Œã§ãããã圱é¿åã®ããã¡ãã»ã³ãžã£ãŒãã®è²æã«äœåãã«ãæäŸããããšãå«ãŸããŠããŸããã
Nassã®æŽé²ã«ãããšããããã®åãçµã¿ã¯ãåºåãææãã£ã³ããŒã³ãæ£è ãžã®æ¯æããä¿¡é Œã§ããã³ãã¥ããã£æŽ»åå®¶ãžã®æ¯æãã«ãšã©ãŸãããå Žåã«ãã£ãŠã¯ãå»çåŸäºè ãžã®çŽæ¥çãªééçã€ã³ã»ã³ãã£ããå«ãŸããŠããŸããã
ã±ã³ã¿ãããŒå·ïŒã¡ãã£ã±ã€ãã¯ãã¡ãã£ã±ã€ãã®ã¯ã¯ãã³æ¥ç𮿣è 1人ã«ã€ãæå€§250ãã«ãå»åž«ã«æ¯æã£ãã
ã±ã³ã¿ãããŒå·ã®Anthem Blue Cross and Blue Shield Medicaidã¯ã2021幎ã«å»åž«ã«å¯ŸããŠããæ£è ãã¯ã¯ãã³æ¥çš®ãåããéžæãããã®ãå©ããããã®ã€ã³ã»ã³ãã£ããæäŸããããšã§ãããªãã®ããŒãã¯ãŒã¯ãè©äŸ¡ããŸã ããšäŒããŸããã
ã¯ã¯ãã³æ¥çš®è ãå€ããã°å€ãã»ã©ãäžäººåœããã®ã€ã³ã»ã³ãã£ãã¯é«ããªãã
Anthem Medicaidã®ã³ããŒãã§æäœ25äººã®æ£è ã蚺çããŠããå»åž«ã«å¯ŸããŠãAnthem Medicaidã¯2021幎9æ1æ¥ãŸã§ã«ã¯ã¯ãã³æ¥çš®ãè¡ãã€ã³ã»ã³ãã£ããæäŸãããã®é¡ã¯ã³ããŒãã®30ïŒ ã«ã¯ã¯ãã³æ¥çš®ããå»åž«ã«ã¯1人åœãã20ãã«ã®ããŒãã¹ã75ïŒ ã«æ¥çš®ããå»åž«ã«ã¯1人åœãã125ãã«ããã®éã«ããã€ãã®æ®µéçãªã¹ãããããããŸããã
æéãçµã€ã«ã€ããŠãçã¯äžæããã
2021幎9æ1æ¥ãã12æ31æ¥ã®éã«ãå»åž«ã¯ãæ£è ã³ããŒãã®30ïŒ ã«ã¯ã¯ãã³ãæ¥çš®ãã人ã«ã€ããŠã¯æ°ãã«æ¥çš®ãã人1人åœãã100ãã«ãæ£è ã³ããŒãã®75ïŒ ã«ã¯ã¯ãã³ãæ¥çš®ãã人ã«ã€ããŠã¯æ°ãã«æ¥çš®ãã人1人åœãã250ãã«ã®ç¯å²ã®æ¯æããåããã
2022幎ãAnthemã®ãããã€ããŒã€ã³ã»ã³ãã£ãããã°ã©ã ã¯ãå®é¡å¶ã«å€æŽãããŸããããããã€ããŒã¯ãæ°ãã«ã¯ã¯ãã³æ¥çš®ãåããã¡ãã£ã±ã€ãæ£è 1人åœãã50ãã«ãåãåããŸãããããã«ã¯ã2022幎1æ1æ¥ãã12æ31æ¥ãŸã§ã«ã¯ã¯ãã³æ¥çš®ãåããçåŸ6ã«æãã4æ³ãŸã§ã®åäŸãš12æ³ä»¥äžã®åäŸãããã³2022幎6æ1æ¥ãã12æ31æ¥ãŸã§ã«ã¯ã¯ãã³æ¥çš®ãåããçåŸ5æ³ãã11æ³ãŸã§ã®åäŸãå«ãŸããŸããã
Medi-CalïŒäœæåŸã®åäŸãæè²äººçš®ãžã®ã¯ã¯ãã³æ¥çš®ã«3å5åäžãã«ã®ã€ã³ã»ã³ãã£ããæäŸããã
ã«ãªãã©ã«ãã¢å·ä¿å¥å»çãµãŒãã¹å±ïŒDHCSïŒã¯2021幎8æ6æ¥ãMedi-Calã®1400äžäººã®å絊è ã®ã¯ã¯ãã³æ¥çš®ãä¿é²ããããããããã€ããŒãžã®2å5000äžãã«ãšã¯ã¯ãã³å絊è ãžã®ã®ããã«ãŒããªã©éé以å€ã®çŽæ¥æ¯æãã«1åãã«ã®åèš3å5000äžãã«ã®ã€ã³ã»ã³ãã£ããçºè¡šããŸããã
3å5000äžãã«ã®ãã¡ã1å7500äžãã«ã¯å·ã®äžè¬è³éããã1å7500äžãã«ã¯é£éŠæ¿åºã®è³éãã調éããããè³éæäŸæéã¯2021幎9æ2æ¥ãã2022幎2æ29æ¥ãŸã§ã§ãã£ãã
ãã®ããã°ã©ã ã¯ã"å¥åº·ã®å ¬å¹³æ§ "ã®åã®äžã«ããããŒãžãã±ã¢ãã©ã³ã«ã€ã³ã»ã³ãã£ããæäŸããããã¬ã¹ãªãªãŒã¹ã®äžã§ãDHCSãã£ã¬ã¯ã¿ãŒã®ãŠã£ã«ã»ã©ã€ãããŒã³ã¯ãã¡ãã£ã«ã«å絊è ã®çãäžããããšãäžå¯æ¬ ã§ãããšè¿°ã¹ãããã«ãªãã©ã«ãã¢ã¯ãçãå®å šã§ãããšãã«ã®ã¿å®å šã§ãã ãããã ã
Nassã¯ããã®ããã°ã©ã ããçŸç 管çäºé²ã»ã³ã¿ãŒã®ãã£ã¬ã¯ã¿ãŒRochelle WalenskyãCNNã«ãã¯ã¯ãã³ã¯ãŠã€ã«ã¹ææãé²ããªããšèªã£ãç¿æ¥ã«å±éãããããšãææããŸããããæããã«ççŸããŠããããšNassã¯The Defenderã«èªã£ãã
ãã®è³éã¯ãã¯ã¯ãã³ã®æåçãäœãã¡ãã£ã±ã€ãå絊è ïŒåšå® æ£è ãæè²äººçš®å°åã12æ³ãã25æ³ã®è¥è ãè€æ°ã®æ ¢æ§çŸæ£ãæã€50æ³ãã64æ³ã®äººã ïŒã察象ãšãããããã€ããŒãè¬å±ã«å¯Ÿããã¢ãŠããªãŒã掻åãã¯ã¯ãã³æ¥çš®æŽ»åã奚å±ãããã®ã§ããã
çºè¡šåœæã12æ³ä»¥äžã®Medi-Calå絊è ã®ãã¡ãCOVID-19ã¯ã¯ãã³ãå°ãªããšã1åæ¥çš®ãã人ã¯45.6%ã«éããŸããã§ããããã«ãªãã©ã«ãã¢å·æ°å šäœã§ã¯76%以äžã«éããŠããŸãã
DHCSã®è³éæŽå©ã«ã¯ãã³ãã¥ããã£ããŒã¹ã®çµç¹ãããŒããã³ã¯ãã¢ããã«ã·ãŒã°ã«ãŒããä¿¡ä»°ã«åºã¥ãçµç¹ãžã®æ¯æããå«ãŸããŠããŸãããé£éŠæ¿åºã®ã¯ã¯ãã³ã¡ãã»ãŒãžãåºãããèã®æ ¹ã代ç人ãšããŠæŽ»åããèã®æ ¹ã®ãªãŒããŒã«è³éãæäŸãããšãããã®éèŠãªæŠç¥ã¯ããã³ãããã¯ãéããŠåºãŸããŸããã
ãã®å©æéãšCAIRVaxGrantãçµã¿åãããããšãå¯èœã§ããã®å©æéã¯ãã«ãªãã©ã«ãã¢äºé²æ¥çš®ã¬ãžã¹ããªïŒCAIRïŒã«éå»ã®é»åå¥åº·èšé²ã®äºé²æ¥çš®ããã¹ãŠå ¥åããããã«ããããã€ããŒã«æå€§1äžãã«ãæäŸãããã®ã§ããã
ãã®å©æéã§ã¯ãç«ã¡äžãè²»çšä»¥éã¯ãã±ã³ã¿ãããŒå·ã®ããã°ã©ã ãšåæ§ã«ããç¹å®ã®äºé²æ¥çš®ç®æšã®éæãã«çŽæ¥çµã³ã€ããŠæ¯æãããããšãèŠå®ãããŠããŸããã
ã«ãªãã©ã«ãã¢å·ã®èšç»ã«ããã奚å±éæ¯æãã®ä»çµã¿ã¯è€éã§ãé¡ã人å£çµ±èšã«ãã£ãŠç°ãªãããå šäœãšããŠã¡ãã£ã±ã¢å絊è ã®äžã§ã¯ã¯ãã³æ¥ç𮿣è ã®å²åãå¢å ãããç¹å®ã®ãã³ãããŒã¯ãæºãããå»çæäŸè ã«ééçå ±é ¬ãæ¯æããã®ã§ãã£ãã
ãã®ã€ã³ã»ã³ãã£ãæ§é ã§ã¯ãå»çæäŸè ã¯å ±é ¬ãåŸãããã«ç¹å®ã®ã¯ã¯ãã³æ¥çš®ç®æšãéæããªããã°ãªããªãã£ããç¹ã«ã¿ãŒã²ããã°ã«ãŒãã®ã¯ã¯ãã³æ¥çš®çãé«ããããšã«æåãããããã€ããŒã¯ãããã€ããã©ãŒãã³ã¹ã»ããŒã«ãã«å ¥ããããã¡ãã£ã±ã¢å絊è ã®ã¯ã¯ãã³æ¥çš®çãããŒã¹ã©ã€ã³ãã75ïŒ é«ãããããã¯é¡ã®äžè¬çãªæ¥çš®çã®10ïŒ ä»¥å ã«å€§å¹ ã«åŒãäžããããšã§è¿œå å ±é ¬ãåãåãããšãã§ããã
奚å±éã®æ¯æãæ§é ãæ±ºå®ããæ¹çšåŒã§ã¯ã人å£çµ±èšåŠçãªã°ã«ãŒãã®éã¿ãç°ãªã£ãŠãããäŸãã°ã12æ³ãã25æ³ã®ã¯ã¯ãã³æ¥çš®è ã¯ããã以äžã®å¹Žéœ¢ã®æ¥çš®è ãããé«ããŠã§ã€ããå ããæ¥çš®çãæãäœã2ã€ã®äººçš®ã»æ°æã°ã«ãŒãã®æ¥çš®è ãé«ããŠã§ã€ããå ããã
ä»å¹Žã®1æ21æ¥ãŸã§ã«ããã®2å5åäžãã«ã®ããã·ã¥ã«ãããããããMedi-Calã®ã¯ã¯ãã³æ¥çš®ã¯52.9%ã«ããå¢ããªãã£ãã
ã¡ãã£ã±ã€ãã¯ãCOVIDã¯ã¯ãã³ãæäžããããã«ãä»ã®äºé²æ¥çš®ãããå€ãã®éé¡ãå»åž«ã«æ¯æãã
ã¢ã¡ãªã«ã³ã»ã¬ã¹ãã¥ãŒã»ãã©ã³æ³ã®äžç°ãšããŠããã€ãã³æ¿æš©ã¯COVID-19ã¯ã¯ãã³æ¥çš®ããã°ã©ã ã«å šé¡åºè³ããå¥åº·ä¿éºã®æç¡ã«ãããããã¯ã¯ãã³ãç¡æåããŸããã
ç¡ä¿éºè ãäœä¿éºè ã®è²»çšãã«ããŒããããã«ãä¿å¥è³æºãµãŒãã¹å±ïŒHRSAïŒã¯ãç¡ä¿éºè ããã°ã©ã ãšCOVID-19é©çšæŽå©åºéãéããŠãã¯ã¯ãã³æäžã«ããããããã€ããŒè²»çšãæ¯æããŸããã
æãæ»ãã¯åœå ã®ã¡ãã£ã±ã¢çã«åºã¥ããŠããŸãããããã®çãèšå®ããã¡ãã£ã±ã¢ïŒã¡ãã£ã±ã€ããµãŒãã¹ã»ã³ã¿ãŒïŒCMSïŒã¯ãæéã®çµéãšãšãã«æãæ»ãçãåŒãäžããŠããŸãã2021幎3æ14æ¥ãŸã§ãHRSAã¯ã1åæ¥çš®ã®ã¯ã¯ãã³ãŸãã¯2åã·ãªãŒãºã®2åç®ã®æ¥çš®ã«å¯ŸããŠ28.93ãã«ã2åã·ãªãŒãºã®1åç®ã®æ¥çš®ã«å¯ŸããŠ16.94ãã«ãæ¯æããŸããã
2021幎3æ15æ¥ããããã®æéã¯ã1åã®æ¥çš®ã«ã€ã40ãã«ããå®¶åºå ãã§ã®æ¥çš®ã«ã¯75.50ãã«ã«åŒãäžããããŸããã
Nassã¯ãæåã®æ¯æãã¯ä»ã®ã¯ã¯ãã³ã«å¯Ÿããã¡ãã£ã±ã€ãã®æ¯æããšåãã§ãã£ãããæ¯æé¡ã®å¢å ã¯éåžžã®åéæ§é ããã®éžè±ãæå³ãããšè¿°ã¹ãã
éåžžãCMSãç¹å®ã®ãµãŒãã¹ã«å¯Ÿããã¡ãã£ã±ã¢ã®æ¯æãã倿Žããå Žåã¯ããã¹ãŠéç¥ãšã³ã¡ã³ãã«ããã«ãŒã«ã¡ã€ãã³ã°ãçµãªããã°ãªããªããããCOVID-19ãã³ãããã¯ã®éã«æéãç¯çŽããããã«ãã¯ã¯ãã³æäžã«å¯Ÿããæ¯æããå¢ããåã«ãã®ã«ãŒãããã€ãã¹ããããšJAMAã¯å ±åããŠããã
CMSã¯ããã®æ¯æãå¢ã¯COVID-19ã¯ã¯ãã³æ¥çš®ãæ¡å€§ããããã®ãã®ã§ããæ¢åã®ã¯ã¯ãã³æ¥çš®å Žæã®æ¡å€§ãæ£è ã®ã¢ãŠããªãŒããšæè²ã®å®æœãã¹ã¿ããã®è¿œå éçšãªã©ããããã€ããŒãåãè¡åãããµããŒããããšè¿°ã¹ãŠããããšãã«ã¹ã±ã¢ã»ãã¡ã€ãã³ã¹ã»ãã¥ãŒã¹ã¯äŒããŠããã
